Keeping Weight Off: study protocol of an RCT to investigate brain changes associated with mindfulness-based stress reduction.

INTRODUCTION: Obesity is a growing epidemic fuelled by unhealthy behaviours and associated with significant comorbidities and financial costs. While behavioural interventions produce clinically meaningful weight loss, weight loss maintenance is challenging. This may partially be due to failure to target stress and emotional reactivity. Mindfulness-based stress reduction (MBSR) reduces stress and emotional reactivity and may be a useful tool for behaviour change maintenance. This study seeks to provide a mechanistic understanding for clinical trials of the benefits of MBSR for weight loss maintenance by examining changes in functional connectivity (FC) and the association of these changes with clinical outcomes. METHODS AND ANALYSIS: Community-dwelling individuals (n=80) who intentionally lost ≥5% of their body weight in the past year will be recruited and randomised to an MBSR programme or educational control. FC using resting-state functional MRI will be measured at baseline and 8 weeks. Psychological factors, health behaviours, body mass index and waist circumference will be measured at baseline, 8 weeks and 6 months post intervention. A 12-month telephone follow-up will assess self-reported weight. Analyses will characterise FC changes in response to MBSR in comparison with a control condition, assess the relationship between baseline FC status and pre-post MBSR changes in FC and investigate the association of FC change with changes in psychological factors and weight loss maintenance. ETHICS AND DISSEMINATION: The University of Massachusetts Medical School Institutional Review Board has approved this study, Declaration of Helsinki protocols are being followed, and patients will give written informed consent. The Independent Monitoring Committee will monitor protocol adherence. Results from the study will be disseminated to the medical community at conferences and submitted for publication in peer-reviewed journals when the last patient included has been followed up for 12 months. TRIAL REGISTRATION NUMBER: NCT02189187. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

RCT Entities:   Population Interventions Outcomes

This is a timely and innovative study that will advance the field of mindfulness research and increase understanding of its mechanisms of action, setting the stage for a comprehensive clinical trial.

The intervention is low-risk, highly accessible, low-cost and is implemented in a real-world clinical population and community setting. The control course was specifically designed to serve as an attention control for mindfulness-based stress reduction.

The cost of a neuroimaging biomarker could be considered a limitation for large-scale clinical trials, but the insights about neural mechanisms of change cannot be obtained with other methods.

Introduction

Unhealthy behaviours such as overeating and sedentary lifestyles are major contributors to cardiovascular disease, cancer, type 2 diabetes and other chronic conditions. They have produced a rapid rise in obesity that threatens to reverse recent gains in life expectancy1 and accounts for a large percentage of premature deaths in the USA.2 The number of obese adults in the USA is expected to rise by 65 million from 2010 to 2030, resulting in a predicted additional 6–8 million cases of diabetes, 5–6.8 million cases of heart disease and stroke, and over 400 000 cancer cases.3 For each 5 kg/m2 increase in Body Mass Index (BMI), the risks of oesophageal cancer and colon cancer in men increase by 52% and 24%, respectively, and the risks of endometrial cancer, gall bladder cancer, and breast cancer in women increase by 59%, 59% and 12%, respectively.4

In addition to significant morbidity, obesity has a substantial financial impact due to healthcare costs and decreased productivity. Obesity-related US healthcare costs were $2.5 trillion in 2009 and are predicted to rise by at least $22 billion/year by 2020 and $48 billion/year by 2030.3

Weight loss is vital for reducing these extensive health and economic burdens, and even minimal weight loss has a meaningful impact. In an overweight and obese population in Ireland, a 1 kg/m2 decrease in BMI led to 26 fewer cases of chronic disease per 1000 men and 28 fewer cases per 1000 women.5 Similarly, a 1% decrease in BMI across the US population (1 kg weight loss for the average adult) is predicted to prevent 2.1–2.4 million cases of diabetes, 1.4–1.7 million cases of cardiovascular disease, and 73 000–127 000 cancer cases; and would only require reducing caloric intake by 20 kcal/day for 3 years.3

Current obesity treatments include lifestyle modification, pharmacotherapy and surgical options. A systematic review of various approaches to weight loss maintenance found that behavioural interventions involving food intake and physical activity led to significant, albeit small, improvements in weight loss maintenance at 12 months after the intervention.6 Exercise programmes alone, however, may be most effective in the adoption phase.7 Similarly, certain medications such as orlistat and sibutramine facilitate weight loss but commonly only work short term when used alone, and may have unfavourable side effects.8 Bariatric surgery can be effective long term, but it can be associated with perioperative surgical risks and weight regain is common.8 Also, many patients are unwilling or ineligible to undergo surgery.

Many interventions are effective for initiating weight loss and other health behaviour changes, but they have shown only limited ability to affect significant, long-term behaviour change in the majority of adults.7 9–11 In part, this may be attributable to a failure of existing interventions to adequately address the effects of stress and emotional reactivity on relapse to unhealthy behaviours and failure to maintain long-term behaviour change. Perceived stress and symptoms of emotional reactivity (depression, anxiety, anger) are linked to unhealthy lifestyle behaviours12–15 and predict worse outcomes in maintenance studies.16–18 Indeed, studies of health behaviour change have demonstrated that perceived stress19–21 and indices of emotional reactivity such as anxiety,22–24 depression and anger25–27 are associated with poor outcomes. In contrast, positive affect is associated with improved outcomes.28 29

Mindfulness, defined as paying attention to one's inner and outer experiences in a non-judgmental manner from moment to moment,30 has been associated with healthy behaviours. Dispositional mindfulness in obese patients awaiting bariatric surgery was found to be positively associated with a restrained eating style (using restrictive control over food to lose weight) but negatively associated with emotional (eating in response to emotional states) and external eating behaviours (eating in response to external cues). Mindfulness may discourage external eating by increasing sensitivity to hunger and satiety such that these internal cues guide behaviour instead. In addition, mindfulness may prevent emotional eating by encouraging acceptance of negative feelings, lowering stress and thus promoting distinction between emotion and hunger. Finally, mindfulness has been shown to decrease impulsivity which may reduce unhealthy eating behaviours.31

Several mindfulness-based or mindfulness-associated practices are promising agents of behaviour change, but we need to understand their neural mechanisms in order to optimise their use. Mindfulness-based stress reduction (MBSR) is a psycho-educational programme that teaches emotional and physical self-care. Participants receive training in formal and informal mindfulness practices and learn about the role of good nutrition, rest and exercise, as well as the role played by thoughts and emotions in physical and emotional health. They are taught how to cultivate a non-reactive awareness of mental and physical experience in an effort to increase self-efficacy and reduced emotional reactivity—leading to healthier lifestyle practices. A recent comparative effectiveness review found moderately strong evidence for mindfulness meditation programmes, particularly MBSR, for anxiety, depression and pain compared with non-specific active controls, and weaker evidence for stress and health-related quality of life.32 Evidence is mixed regarding the effectiveness of mindfulness-based interventions on weight loss, at least with relatively short follow-up periods.33 Whether MBSR can support maintenance of weight loss following successful initiation of health behaviour change warrants investigation based on its ability to lower emotional and behavioural reactivity to stress and negative emotions, risk factors for relapse to unhealthy behaviours. Importantly, an understanding of neural targets and mechanisms of change is necessary for specifying for whom mindfulness is likely to work and for optimising the intervention for maximal effectiveness. Mindfulness may work better in specific subpopulations, as seen in a group of women with specific endogenous opioidergic activity who were found to be more receptive to mindfulness training in an effort to decrease pleasure eating.34 Additionally, efficacy of mindfulness-based therapy has been strongly positively associated with dispositional mindfulness of participants and therapists.35 Neuroimaging, specifically resting-state functional MRI (fMRI), is a powerful approach to identifying mechanisms of change for MBSR involving the role of emotion regulation in maintenance of health behaviour change.

Neuroimaging studies report an association between MBSR and changes in functional connectivity (FC) that may reflect improved attention, sensory processing and reflective awareness of sensory experience.36 37 Mindfulness has also been shown to alter resting-state FC of the amygdala, a region involved in physiological stress response. A randomised controlled trial (RCT) found that a 3-day intensive mindfulness training reversed the effects of stress on the amygdala–subgenual anterior cingulate cortex in a group of stressed unemployed adults in the community.38 This mindfulness training was also shown to increase resting-state FC between the default mode network and the left dorsolateral prefrontal cortex, an area involved in top-down executive control.39 However, no previous studies have examined how mindfulness training affects the neural circuitry of emotion regulation in a weight loss sample and little is known about mechanisms of behaviour change in people undergoing mindfulness training.

Gaps in knowledge

Emerging evidence suggests that mindfulness may be helpful for changing behaviours such as overeating40 but the mechanistic knowledge of how mindfulness facilitates behaviour change is not known. Efforts to fill this gap could enhance our ability to identify likely ‘responders’ and thus optimise intervention efforts, consistent with current trends towards personalised medicine approaches. Specifically, we are lacking knowledge of specific neural targets of mindfulness training to inform clinical trials of health behaviour change and maintenance of change. In addition, data on long-term outcomes of mindfulness training are lacking.

Understanding the neural mechanisms that link MBSR to changes in emotional regulation and behaviour are a critical next step in tapping the potential of MBSR as an intervention for behaviour change and maintenance. A validated biomarker will allow investigators to monitor fidelity of intervention delivery, adherence and dose–response in clinical trials. If validated as a biomarker, changes in FC will allow future studies to determine characteristics of individuals who are most responsive to MBSR and which components of the mindfulness intervention are most active, and may enable development of a more compact and potent intervention. FC may also help identify subsets of high-risk patients that would benefit from specific tailoring of the intervention. It is worth noting that if clinical trials prove that MBSR prevents weight regain, MRIs would not be required in a larger dissemination study or as the intervention is deployed in a large-scale public health approach.

Study aims and hypotheses

To characterise FC, psychological, behavioural and anthropometric changes in response to MBSR and the comparison condition, we will randomise a sample of 80 participants who have intentionally lost ≥5% of their body weight during the previous year to MBSR or an attention control specifically designed to be structurally equivalent to MBSR. Study aims and hypotheses are as follows.

Our first primary aim is to characterise FC changes in response to MBSR and the comparison condition. We hypothesise that participants randomised to the MBSR condition will experience greater increases in FC from baseline to post intervention (Hypothesis 1), and participants with higher baseline FC will show less change in response to MBSR (Hypothesis 2).

Our second primary aim is to investigate the association of FC change with changes in psychological factors and maintenance of weight loss at 8 weeks and 6-month follow-up. We hypothesise that increases in FC will be associated with improvement in depressive symptoms (Hypothesis 3) and inversely related to decreased weight (BMI) and total waist circumference (Hypothesis 4).

Our third primary aim is to assess changes in BMI at 6 and 12 months to obtain preliminary measures of effect size and variability by study group for future clinical trials.

As secondary aims, we will use mediation analysis to determine how change in FC is explained by (1) class attendance, (2) self-reported time in homework practice, (3) self-reported time for each specific component of the multifaceted training programme and (4) trait mindfulness. An exploratory aim is to examine correlations of change in FC with changes in additional psychological factors (perceived stress, trait anger, trait anxiety, positive affect) and health behaviours (healthy eating, physical activity, sleep quality).

Methods

Study design

The ‘Keeping Weight Off’ study is a randomised, prospective, two-armed, controlled trial. A sample of 80 participants from the community, who have intentionally lost at least 5% of their body weight during the previous year, will be equally randomised into two groups: an MBSR programme and a healthy living course (HLC)—an attention control specifically designed to be structurally equivalent to MBSR.41 The HLC uses the same format of 8-weekly classes lasting 2.5 hours, and controls for attention and other non-specific factors including staff interactions, psychoeducation about health and stress management, classroom format, homework, group process and data collection.41 Our main outcome measures are resting-state FC, depression symptoms, BMI and waist circumference. FC, psychological factors, health behaviours, BMI and waist circumference will be measured at baseline and 8 weeks. Psychological factors, health behaviours, BMI and waist circumference will also be measured at 6 months. In addition, a telephone follow-up will be attempted on participants at 12 months to assess weight.

Total planned enrolment is 80 participants. Screening for eligibility criteria, baseline visits and follow-up visits will take place at University of Massachusetts Medical School (UMMS), Worcester, Massachusetts. All MBSR classes will be conducted at the UMMS Center for Mindfulness in Shrewsbury, Massachusetts.

Study participants

We will recruit participants who range in age from 25 to 60 (chosen to minimise age-related changes in FC), have intentionally lost ≥5% of their body weight during the previous year and are motivated to maintain this weight loss. Individuals will be excluded if they have participated in an MBSR course, regular meditation practice or any other form of meditative practice (such as yoga, Tai Chi or contemplative prayer), for more than an average of 20 min per week within the past 2 years. Full inclusion and exclusion criteria are listed in table 1.

Table 1

Eligibility criteria

Inclusion criteria:

Exclusion criteria:

Men and women Right or left handed Ages 25–60 Intentionally lost ≥5% of body weight during the previous year Intending to maintain weight loss BMI >25 kg/m2 in the past 2 years and greater than 20.5 kg/m2 at time of study entry Under the care of a primary care physician for at least the last year prior to screening Able to communicate by telephone with research staff Have a healthcare provider, personal trainer or weight-loss counsellor who can complete and sign a form indicating the amount and timing of their weight loss OR have a dated photograph or weight loss diary71

Weight >300 lbs (limitation of MRI scanner) Prior participation in an MBSR course Regular meditation practice (or any other form of meditative practice, such as yoga, Tai Chi, or contemplative prayer) for more than an average of 20 min/week within the past 2 years Serious psychiatric, cognitive or medical disorder Alcohol/substance abuse or dependence in past 6 months Any conditions that are incompatible with MRI Structural brain damage as determined by an independent neuroradiologist, based on T1W 3D TFE sagittal and T1W FFE axial images History of an eating disorder, diabetes mellitus or medications for diabetes mellitus Medication that affects weight (weight loss medications, corticosteroids, antipsychotics) History of weight loss surgery Participation in another weight management research study Regain of >3% of total body weight in the 2 months prior to study entry Childbirth in the past 6 months Claustrophobia, or any MRI incompatible implants Pregnant or planning to become pregnant Unable to consent

3D, three dimensional; BMI, Body Mass Index; FFE, Turbo Flash Field Echo; MBSR, mindfulness-based stress reduction; T1W, T1 weighted; TFE, Turbo Field Echo.

Eligible participants will proceed with the baseline visit prior to randomisation, including collection of demographic information about age, education, marital status, occupation and current employment status, followed by questionnaires and fMRI scan. The full study schedule of recruitment, treatment and assessments is described in table 2. All participants will provide informed consent. This process will be conducted by the study coordinator in person prior to the baseline visit, following the protocol established by the University of Massachusetts Institutional Review Board (IRB). Study staff will keep in touch with participants regarding attendance and homework completion and provide support and encouragement to continue with the intervention if participants express dissatisfaction. Participants who drop out of the intervention will be asked to return for all follow-up visits to complete all outcome data collection.

Table 2

Study schedule of recruitment, treatment and assessments as a function of time points (according to the SPIRIT 2013 figure guidelines)

	Duration of the study
	Recruitment	Baseline	Post-treatment (8 weeks)	Follow-up (6 months)	Follow-up (12 months)
TIME POINT	t0	t1	t2	t3	t4
RECRUITMENT
Screening for inclusion/exclusion criteria	X
Informed consent		X
Assignment to treatment arms	X
TREATMENT
MBSR		X	X
HLC		X	X
ASSESSMENT
SCID-IV	X
fMRI		X	X
Weight		X	X	X	X
Height (and BMI)		X	X	X
Waist circumference		X	X	X
CES-D		X	X	X
PSS-14		X	X	X
STAI-T		X	X	X
STAXI-II		X	X	X
Satisfaction with life		X	X	X
Emotion Regulation Questionnaire		X	X	X
Eating Behaviour Inventory		X	X	X
Internal Disinhibition Subscale of the Eating Inventory		X	X	X
Paffenbarger Physical Activity Scale		X	X	X
Pittsburgh Sleep Quality Index		X	X	X

CES-D, Center for Epidemiologic Studies Depression Scale; HLC, healthy living course; MBSR, mindfulness-based stress reduction; PSS-14, Perceived Stress Scale; SCID-IV, Structured Clinical Interview for DSM-IV; SPIRIT, Standard Protocol Items: Recommendations for Interventional Trials; STAI-T, State-Trait Anxiety Inventory—trait version; STAXI-II, State-Trait Anger Expression Inventory-II.

Study recruitment

Recruitment will be conducted using advertising in the community (internet, flyers and social media) of Worcester County, which has a population of over 800 000, as well as a two-stage process to recruit outpatients from the UMass Memorial Medical Center using the electronic medical record. The largest healthcare system in Central and Western Massachusetts, the medical centre has a large population from which to draw, with nearly 70 000 patient visits for primary care alone, and a Weight Center that sees nearly 1000 new patients per year. Our team has an excellent record of recruitment and retention in our previous overweight/obese subjects using these methods.

First, with a Health Insurance Portability and Accountability Act (HIPAA) waiver authorisation a search query will be conducted with basic eligibility criteria, and second, identified records will be reviewed to exclude causes of weight loss such as serious illness or weight loss medications. Web-based and telephone screening will determine whether they meet inclusion criteria. Further screening will be done in person to gather a medical history and complete the Structured Clinical Interview for DSM-IV (SCID) to exclude participants with a serious psychiatric, cognitive or medical disorder or a history of alcohol or substance abuse or dependence in the past 6 months.

Randomisation and study blinding

Study participants will be equally randomised to either the MBSR intervention arm or HLC arm based on a permuted blocks randomisation scheme. In this procedure, treatment allocations will be made within blocks so that the numbers assigned to each arm are equal after each block has been filled. Blocks of various sizes (2, 4, 6) will be used in random order, to facilitate allocation concealment, that is, to make it nearly impossible to determine the treatment assignment based on a pattern of previous treatment allocations. Randomisation will be implemented using sealed envelopes by the study coordinator who will be the only member of the research team who is not blind to treatment assignment. A unique identification number will help to ensure that blindness is maintained throughout the study. All members of the research team involved in data analysis will be blind to treatment assignment.

To address the possibility that an imbalanced distribution of baseline FC could mask important findings, we will employ a non-stratified permuted-block randomised design with an interim analysis of the distribution of baseline FC. If important imbalances are found, we will implement recruitment strategies to increase enrolment of participants who have baseline FC with a specified range combined with covariate-adaptive randomisation techniques. Residual imbalances will be addressed with post hoc statistical adjustment.

Assessments

Resting-state FC

In contrast to task-evoked functional and effective connectivity studies, resting-state fMRI enables examination of the brain's intrinsic functional connections in the absence of externally controlled stimuli or tasks.42 43 FC is responsive to changing levels of stress,44 intense training on a task45 and recently, meditation practice including MBSR.46 47 FC has been shown to have remarkable consistency and moderate-to-high test–test reliability over periods of months to a year as well.48 49 All MRIs will be acquired on the 3T scanner (Philips Achieva) in the UMMS Advanced MRI Center. Three-dimensional high-resolution structural T1-weighted MR images will be obtained to provide anatomical landmarks. Following the structural imaging, resting-state fMRI data will be collected. Participants will be instructed to remain relaxed with eyes closed as fMRI images are continuously collected for 10 min. The duration of the entire MRI procedure will be 30 min.

Psychological symptoms

The Center for Epidemiologic Studies Depression Scale (CES-D)50 depression symptom score is a primary outcome. Additional outcomes include perceived stress, anxiety, anger, positive affect and emotion regulation, which will be assessed using the following measures, respectively: the Perceived Stress Scale (PSS-14),51 the State-Trait Anxiety Inventory—trait version (STAI-T),52 the State-Trait Anger Expression Inventory-II (STAXI-II) trait anger subscale,53 the Satisfaction with Life Scale54 and the Emotion Regulation Questionnaire.55

Health behaviours

Health behaviours will be assessed using the Eating Behaviour Inventory,56 the Internal Disinhibition Subscale of the Eating Inventory,57 the Paffenbarger Physical Activity Scale58 and the Pittsburgh Sleep Quality Index (PSQI),59 respectively.

Anthropometrics

Procedures are adapted from the Centers for Disease Control (CDC)'s Anthropometry Procedures Manual.60 For the measurement of height and weight, the Seca 213 Portable stadiometer and the tanita, BWB-800 electronic scale will be used and measurements will be taken twice and averaged to assure reliability. Measurement of waist circumference will be taken directly on the skin using measuring tape placed just above top of the iliac crest on each side.

Potential mediators and confounders

Intervention engagement will be assessed with class attendance and a home practice log. Treatment expectancy and credibility will be assessed with the Credibility/Expectancy Questionnaire (CEQ)61 modified slightly to substitute the word ‘Class’ for ‘Therapy’ in the instructions. Secondary analyses will examine how change in FC is explained by (1) class attendance, (2) self-reported time in homework practice, (3) self-reported time for each specific component of the multifaceted training programme and (4) trait mindfulness as measured by the Five Facet Mindfulness Questionnaire (FFMQ).62

Interventions

Experimental condition: MBSR

MBSR, described above, is taught in eight weekly classes and one all-day retreat. Homework assignments include formal meditation practices and informal practices during daily life. Classroom activities teach formal meditation practices including sitting meditation, body scan, mindful yoga and walking meditation. Participants also learn to bring awareness in the present moment to aspects of daily life and apply this practice to stressful experiences in order to avoid reflexive or conditioned reactions. The goal of MBSR is to provide participants with these skills for lifelong self-management.

The MBSR classes are taught by certified teachers from the UMass Center for Mindfulness. All teachers have completed the rigorous training and certification for MBSR through the Center for Mindfulness. To further assure fidelity, each class will be reviewed in weekly sessions with a coinvestigator. In addition, the principal investigators will routinely convene the entire clinical research team to monitor the overall fidelity of the MBSR intervention.

Attention control: HLC

The HLC was specifically designed to serve as a control condition for MBSR.41 HLC consists of eight weekly 2-hour classes. Sessions consist of lectures and discussion on the following topics: healthy living, healthy eating, physical activity and health, sleep and health, stress management, time management and unhealthy behaviours (smoking, drinking). The HLC is designed to control for attention and other non-specific factors including staff interactions, psychoeducation about health and stress management, classroom format, homework, group process and data collection.41

Data collection

Electronic data capture (EDC, Research Electronic Data Capture (REDCap)) will be used for all data collection except imaging. Surveys for psychological symptoms, health behaviours and potential mediators and confounders are programmed into the EDC system. During research visits, participants will enter survey responses directly into this system and research staff will enter screening and anthropometric data with periodic checks for quality assurance. All data will be maintained in a secure location accessible only to study personnel. For MRI measures, data will be analysed blind to intervention group by two fMRI experts who perform cross-validity checks.

Data analysis and sample size considerations

We based the study sample size on Hypothesis 1, powered to detect an effect size of 0.32 SDs. This moderate Cohen effect size63 represents differential overtime change for the intervention versus comparison group cast in SD units. The study design calls for a baseline measurement and two follow-up measurements. In addition, we assumed a two-tailed α error of 0.05, and a within-person correlation for overtime measurement of 0.8.64 With these assumptions, 40 participants in each group are needed for 80% power. We will enrol 100 participants (50 randomised to each arm) and allow for up to 20% loss to follow-up, for an effective sample size of 80.

Statistical analysis will begin with univariate summaries of data distributions and examination of longitudinal trends with graphic displays. Bivariate associations will then be examined using the χ2 test, analysis of variance (ANOVA), and the Spearman correlation test. Hypotheses 1 and 2 focus on overtime differences between the two study groups, while Hypotheses 2 and 3 focus on overtime differences for the combined sample. Hypotheses will be formally tested using generalised linear mixed models that represent the clustering of observations within participants as a random intercept, adopt an appropriate link and distribution for the specific outcome and parameterise the intervention effect as a group-time intervention, when appropriate.65 To preserve the power of randomisation, hypothesis testing will be performed on an intent-to-treat basis. As a secondary aim, mediation analysis will determine how change in FC is explained by markers of intervention adherence using techniques as described by MacKinnon.66 67 Sensitivity analyses with multiple imputation with chained equations will address missing data.

Imaging data is preprocessed using Statistical Parametric Mapping (SPM8) software (Wellcome Department of Cognitive Neurology, London, UK) running under the MATLAB environment (Mathworks, Sherborn, Massachusetts, USA). The data are initially corrected for motion (threshold of 2 mm). Further preprocessing of the data includes (1) slice scan time correction, (2) spatial smoothing using a three-dimensional Gaussian filter (4-mm full width at half maximum (FWHM)) and (3) voxel-wise linear detrending and 0.01–0.08 Hz band-pass filtering. Structural and functional data of each participant are then be transformed to standard stereotaxic space68 to facilitate group analysis.

Following the preprocessing steps, FC will be generated using correlational analysis. Left and right amygdalae are used as separate seed regions of interest (ROI). FC maps from each individual seed will then be calculated for each individual subject using Resting-State fMRI Data Analysis Toolkit (REST, http://www.restfmri.net). Each seed ROI will be evaluated using two-way repeated measures ANOVA on a voxel-by-voxel basis (factors: group and imaging day) at the threshold of p<0.05 after accounting for multiple comparisons using the criteria of false discovery rate (FDR).69 Voxels with significantly changed FC within each ROI will then be averaged to generate the FC change for the ROI. This procedure will yield a single value of amygdala-orbitofrontal FC for each participant at each point in time. All ROI definitions are based on Automated Anatomical Labelling (AAL)70 built in the MARSeille Boîte À Région (MarsBAR) toolbox of SPM8. Image analysis will be done blind to group membership.

As a secondary analysis, we will explore FC changes in other brain networks following MBSR using other seed regions. For example, other cortical regions that have been implicated in modulation of limbic reactivity (eg, anterior cingulate) will be examined using a hypothesis-driven approach.

Ethical considerations and dissemination plans

This study is registered as a national clinical trial (NCT02189187) and Declaration of Helsinki protocols are being followed, and patients will give written informed consent. Protocol adherence will be monitored by the Independent Monitoring Committee (for full WHO Trial Registration Data Set information see online supplementary appendix). Results from the study will be disseminated to the medical community at conferences and submitted for publication in peer-reviewed journals when the last patient included has been followed up for 12 months. Negative and inconclusive as well as positive results will be published or made publicly available through the study website http://www.umassmed.edu/keepingweightoff.